These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 29701141)
1. Structure-Based Virtual Screening and Biochemical Evaluation for the Identification of Novel Trypanosoma brucei Aldolase Inhibitors. Ferreira LLG; Ferreira RS; Palomino DL; Andricopulo AD Curr Top Med Chem; 2018; 18(5):397-405. PubMed ID: 29701141 [TBL] [Abstract][Full Text] [Related]
2. Selective irreversible inhibition of fructose 1,6-bisphosphate aldolase from Trypanosoma brucei. Dax C; Duffieux F; Chabot N; Coincon M; Sygusch J; Michels PA; Blonski C J Med Chem; 2006 Mar; 49(5):1499-502. PubMed ID: 16509566 [TBL] [Abstract][Full Text] [Related]
3. Cell permeation of a Trypanosoma brucei aldolase inhibitor: evaluation of different enzyme-labile phosphate protecting groups. Azéma L; Lherbet C; Baudoin C; Blonski C Bioorg Med Chem Lett; 2006 Jul; 16(13):3440-3. PubMed ID: 16632348 [TBL] [Abstract][Full Text] [Related]
4. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors. Demir O; Labaied M; Merritt C; Stuart K; Amaro RE Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413 [TBL] [Abstract][Full Text] [Related]
5. In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase. Herrmann FC; Lenz M; Jose J; Kaiser M; Brun R; Schmidt TJ Molecules; 2015 Sep; 20(9):16154-69. PubMed ID: 26404225 [TBL] [Abstract][Full Text] [Related]
6. Species-Selective Pyrimidineamine Inhibitors of Trypanosoma brucei S-Adenosylmethionine Decarboxylase. Volkov OA; Brockway AJ; Wring SA; Peel M; Chen Z; Phillips MA; De Brabander JK J Med Chem; 2018 Feb; 61(3):1182-1203. PubMed ID: 29271204 [TBL] [Abstract][Full Text] [Related]
7. Structure- and ligand-based structure-activity relationships for a series of inhibitors of aldolase. Ferreira LG; Andricopulo AD Curr Comput Aided Drug Des; 2012 Dec; 8(4):309-16. PubMed ID: 22734708 [TBL] [Abstract][Full Text] [Related]
8. Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode. Spinks D; Smith V; Thompson S; Robinson DA; Luksch T; Smith A; Torrie LS; McElroy S; Stojanovski L; Norval S; Collie IT; Hallyburton I; Rao B; Brand S; Brenk R; Frearson JA; Read KD; Wyatt PG; Gilbert IH ChemMedChem; 2015 Nov; 10(11):1821-36. PubMed ID: 26395087 [TBL] [Abstract][Full Text] [Related]
10. Enzymatic Targets in Trypanosoma brucei. Scotti L; Mendonça FJ; da Silva MS; Scotti MT Curr Protein Pept Sci; 2016; 17(3):243-59. PubMed ID: 26983886 [TBL] [Abstract][Full Text] [Related]
11. In silico drug re-purposing against African sleeping sickness using GlcNAc-PI de-N-acetylase as an experimental target. Rashmi M; Swati D Comput Biol Chem; 2015 Dec; 59 Pt A():87-94. PubMed ID: 26476127 [TBL] [Abstract][Full Text] [Related]
12. Identification of Trypanosoma brucei leucyl-tRNA synthetase inhibitors by pharmacophore- and docking-based virtual screening and synthesis. Zhao Y; Wang Q; Meng Q; Ding D; Yang H; Gao G; Li D; Zhu W; Zhou H Bioorg Med Chem; 2012 Feb; 20(3):1240-50. PubMed ID: 22249121 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors. Li Z; Xin W; Wang Q; Zhu M; Zhou H Eur J Med Chem; 2021 May; 217():113319. PubMed ID: 33725631 [TBL] [Abstract][Full Text] [Related]
14. High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor. Landi G; Linciano P; Tassone G; Costi MP; Mangani S; Pozzi C Acta Crystallogr D Struct Biol; 2020 Jun; 76(Pt 6):558-564. PubMed ID: 32496217 [TBL] [Abstract][Full Text] [Related]
15. Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors. Durrant JD; McCammon JA BMC Pharmacol; 2011 Aug; 11():9. PubMed ID: 21878090 [TBL] [Abstract][Full Text] [Related]
16. Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design. Pizarro JC; Hills T; Senisterra G; Wernimont AK; Mackenzie C; Norcross NR; Ferguson MA; Wyatt PG; Gilbert IH; Hui R PLoS Negl Trop Dis; 2013; 7(10):e2492. PubMed ID: 24147171 [TBL] [Abstract][Full Text] [Related]